Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	May 30, 2026	May 31, 2025	Jun. 01, 2024
Net sales	$ 228,564	$ 208,909	$ 196,460
Cost of sales	157,217	144,109	136,494
Gross profit	71,347	64,800	59,966
Selling, general and administrative expenses	65,717	62,173	59,548
Loss on disposal of property, plant and equipment	13	16	70
(Gain) loss on disposal of healthcare assets and related charges	(847)	5,074	0
Operating income (loss)	6,464	(2,463)	348
Other (income) expense:
Interest income	(544)	(392)	(284)
Foreign exchange	452	(496)	436
Other, net	(922)	(44)	39
Total other (income) expense	(1,014)	(932)	191
Income (loss) before income taxes	7,478	(1,531)	157
Income tax provision (benefit)	1,095	(388)	96
Net income (loss)	6,383	(1,143)	61
Foreign currency translation gain, net of tax	1,582	1,390	149
Comprehensive income	$ 7,965	$ 247	$ 210
Weighted average number of shares:
Common stock - Diluted	12,690	12,298	12,464
Common Stock
Net income (loss) per share:
Common stock - Basic	$ 0.45	$ (0.08)	$ 0
Common stock - Diluted	$ 0.44	$ (0.08)	$ 0
Weighted average number of shares:
Common stock - Basic	12,492	12,298	12,214
Common stock - Diluted	12,690	12,298	12,464
Common Class B
Net income (loss) per share:
Common stock - Basic	$ 0.40	$ (0.07)	$ 0
Common stock - Diluted	$ 0.40	$ (0.07)	$ 0
Weighted average number of shares:
Common stock - Basic	2,042	2,049	2,051
Common stock - Diluted	2,042	2,049	2,051